This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Daewoo Pharmaceutical Ind. Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Sung-Woo Hwang in Anti-Inflammatory and Anti-Angiogenic Research
Introduction
Sung-Woo Hwang is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and anti-angiogenic compositions. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Hwang's latest patents include an anti-inflammatory composition containing macrolactin A and its derivatives. This invention focuses on the anti-inflammatory properties of macrolactin compounds, which are derived from a novel strain of KJS-2 (KCCM10769P). The compounds have been shown to suppress the expression of inducible nitric oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2), which are crucial in the formation of inflammatory mediators. Additionally, these compounds inhibit the production of nitric oxide (NO) and prostaglandin E2 (PGE2), thereby providing excellent anti-inflammatory agents.
Another significant patent by Hwang is an anti-angiogenic composition that also utilizes macrolactin A and its derivatives. This composition has demonstrated strong suppression of angiogenesis in in vivo experiments, indicating its potential as a pharmaceutical treatment for diseases associated with angiogenesis.
Career Highlights
Sung-Woo Hwang is currently associated with Daewoo Pharmaceutical Ind. Co., Ltd., where he continues to innovate in the field of pharmaceutical research. His work is characterized by a commitment to developing effective treatments for inflammatory and angiogenic conditions.
Collaborations
Hwang has collaborated with notable colleagues, including Young-Hoon Ji and Dong-Hee Kim, to advance his research and patent applications. Their combined expertise has contributed to the successful development of innovative pharmaceutical compositions.
Conclusion
Sung-Woo Hwang's contributions to the field of pharmaceuticals through his patents on anti-inflammatory and anti-angiogenic compositions highlight his role as a significant inventor. His work not only showcases innovative research but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile